Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.96 USD | -1.49% | -3.18% | -15.74% |
May. 21 | Oppenheimer Adjusts Savara Price Target to $11 From $9.50, Maintains Outperform Rating | MT |
May. 09 | Savara Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
SAVARA INC. | Bio Therapeutic Drugs | -1.49% | -3.18% | -15.74% | +34.24% | -60.91% | 547M |
- Stock Market
- Equities
- SVRA Stock
- Charts Savara Inc.
- Relative Strength Chart